5-MEO Clinical trials to start on neuropsychiatric diseases
Source: Businessleader.co.uk “Cosmo Feilding Mellen, co-founder and CEO, Beckley Psytech, says: “Our mission is to help patients in need by developing psychedelic medicines into licensed pharmaceuticals. This fundraise shows that our investors…